TOP TIERMARKET NEWSWIRE
News & sentiment

ARROWHEAD PHARMACEUT (ARWR) — News & AI sentiment

ARROWHEAD PHARMACEUT (ARWR) news roundup. 6 stories in the past week, 21 over 30 days. Average 30-day sentiment is 67.1/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $228K — net selling of $228K. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$175K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
6
avg sentiment 65.3/100
30d stories
21
avg sentiment 67.1/100
Insider net (90d)
$228K
0 buys · 1 sells
Congress (90d)
-1
0 buys · 1 sells

Latest stories on ARWR

3d ago
3d ago
7d ago
H.C. Wainwright reiterates Arrowhead Pharma stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
7d ago
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Jul 22
Arrowhead Pharmaceuticals stock jumps on Phase 3 trial results
Investing.com Markets73 · bullishproduct/pr
Jul 22
Jul 22
Jul 22
Jul 21
Jun 30
Jun 29
Jun 22
Jun 18
Jun 16
Open ARWR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →